The Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction In Preclinical Non-diabetic Chronic Kidney Disease

被引:0
|
作者
Posada, Ixchel Lima
Stephan, Yohan
Soulie, Matthieu
Palacios-Ramirez, Roberto
Bonnard, Benjamin
Kolkhof, Peter
Mulder, Paul
Jaisser, Frederic
机构
关键词
Chronic kidney disease; Cardiorenal; Aldosterone;
D O I
10.1161/hyp.80.suppl_1.080
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
A080
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease
    Lima Posada, Ixchel
    Soulie, Matthieu
    Stephan, Yohan
    Palacios Ramirez, Roberto
    Bonnard, Benjamin
    Nicol, Lionel
    Pitt, Bertram
    Kolkhof, Peter
    Mulder, Paul
    Jaisser, Frederic
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (12):
  • [2] The Role of the Non-Steroidal Mineralocorticoid Antagonist Finerenone in Cardiorenal Management
    Beavers, Craig J.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (12) : 1785 - 1790
  • [3] The non-steroidal mineralocorticoid receptor antagonist finerenone is a novel therapeutic option for patients with Type 2 diabetes and chronic kidney disease
    Barrera-Chimal, Jonatan
    Gerarduzzi, Casimiro
    Rossignol, Patrick
    Jaisser, Frederic
    CLINICAL SCIENCE, 2022, 136 (12) : 1005 - 1017
  • [4] The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
    Kintscher, Ulrich
    Edelmann, Frank
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [5] The Role of the Non-Steroidal Mineralocorticoid Antagonist Finerenone in Cardiorenal Management
    Craig J. Beavers
    Current Cardiology Reports, 2022, 24 : 1785 - 1790
  • [6] A comprehensive review of finerenone-a third-generation non-steroidal mineralocorticoid receptor antagonist
    Zhai, Shuhui
    Ma, Baisheng
    Chen, Weiwei
    Zhao, Qini
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [7] Mineralocorticoid receptor antagonism for non-diabetic kidney disease
    Jaisser, Frederic
    Barrera-Chimal, Jonatan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025, 40 : i29 - i36
  • [8] Non-steroidal mineralocorticoid receptor antagonists and cardiorenal outcomes in chronic kidney disease
    Lo, Kevin Bryan
    Rangaswami, Janani
    Vaduganathan, Muthiah
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (04) : 845 - 854
  • [9] Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
    Pandey, Arjun K.
    Bhatt, Deepak L.
    Cosentino, Francesco
    Marx, Nikolaus
    Rotstein, Ori
    Pitt, Bertram
    Pandey, Ambirash
    Butler, Javed
    Verma, Subodh
    EUROPEAN HEART JOURNAL, 2022, 43 (31) : 2931 - 2945
  • [10] Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
    Lee, Seung-Eun
    Kim, Dong-Lim
    Kim, Nan Hee
    ENDOCRINOLOGY AND METABOLISM, 2023, 38 (01) : 43 - 55